Skip to main content

Real-World Evidence (RWE) analytics to increase efficiency of clinical product development

Project description

A real-world remedy for clinical trial failures

Product development in the medical industry usually takes years to materialise and success is not guaranteed. In fact, 85 % of new therapies tested never reach the market because they fail to demonstrate quality, safety or efficacy. Products that pass clinical trials may also fail after they reach the market due to unanticipated side effects. To boost success rates, the EU-funded RWEal project is developing a life analytics platform to provide high-quality, accurate and reliable real-world evidence (RWE) to clinical trials. This will prove useful as clinical trials cannot account for the entire patient population for a particular ailment. Medical product developers will benefit from insights that can only be gained outside the controlled environment of the clinic.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Coordinator

BENETE OY
Net EU contribution
€ 50 000,00
Address
Tykistokatu 4 B
20521 Turku
Finland

See on map

Region
Manner-Suomi Etelä-Suomi Varsinais-Suomi
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 21 429,00